Nikulski Financial’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.42M Buy
5,353
+347
+7% +$355K 1.39% 22
2026
Q1
$4.6M Buy
5,006
+177
+4% +$179K 1.14% 26
2025
Q4
$5.19M Buy
4,829
+1,365
+39% +$1.31M 1.24% 23
2025
Q3
$2.64M Buy
3,464
+103
+3% +$76.6K 0.66% 47
2025
Q2
$2.62M Buy
3,361
+380
+13% +$295K 0.72% 45
2025
Q1
$2.46M Sell
2,981
-31
-1% -$25.8K 0.74% 42
2024
Q4
$2.33M Buy
3,012
+143
+5% +$118K 0.68% 46
2024
Q3
$2.54M Buy
2,869
+816
+40% +$734K 0.76% 42
2024
Q2
$1.86M Buy
2,053
+135
+7% +$108K 0.59% 45
2024
Q1
$1.49M Buy
1,918
+1,062
+124% +$756K 0.49% 54
2023
Q4
$499K Hold
856
0.18% 89
2023
Q3
$460K Buy
856
+31
+4% +$16K 0.19% 88
2023
Q2
$387K Sell
825
-75
-8% -$31.5K 0.16% 93
2023
Q1
$309K Hold
900
0.14% 105
2022
Q4
$329K Hold
900
0.16% 99
2022
Q3
$291K Sell
900
-50
-5% -$15.8K 0.15% 98
2022
Q2
$308K Hold
950
0.15% 99
2022
Q1
$272K Sell
950
-50
-5% -$12.9K 0.12% 108
2021
Q4
$276K Hold
1,000
0.12% 108
2021
Q3
$231K Sell
1,000
-100
-9% -$24.7K 0.11% 107
2021
Q2
$261K Hold
1,100
0.12% 108
2021
Q1
$206K Buy
+1,100
New +$215K 0.11% 119
2020
Q2
Sell
-1,500
Closed -$208K 108
2020
Q1
$208K Hold
1,500
0.18% 94
2019
Q4
$210K Buy
+1,500
New +$174K 0.15% 91

Other funds holding LLY

Nikulski Financial's LLY Position: Q2 2026 in Review

Nikulski Financial increased its Eli Lilly (LLY) stake by 6.9% in Q2 2026, buying an estimated $355K and bringing the position to 5,353 shares worth $6.42M. The position accounts for 1.39% of the portfolio, ranked #22.

Nikulski Financial first reported a position in LLY in Q4 2019 and has held it in 24 quarters since. 2,026 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Nikulski Financial held 5,353 shares of Eli Lilly worth $6.42M as of Q2 2026.
  • Nikulski Financial bought 347 Eli Lilly shares in Q2 2026, an estimated $355K.
  • Eli Lilly made up 1.39% of Nikulski Financial's portfolio in Q2 2026, its #22 holding.
  • Nikulski Financial first reported a position in Eli Lilly in Q4 2019 and has held it in 24 quarters since.
  • 2,026 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Nikulski Financial's 13F filing for Q2 2026, filed 28 Jul 2026.